biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Denali & Bioasis why not

<< Previous

Bullboard Posts

Next >>

Comment by MBT123on Jul 29, 2021 8:20am

141 Views

Post# 33619928

RE:RE:RE:RE:Denali & Bioasis why not

A better delivery system claimed by who? All these companies that have had time to "poke" around and play with the technology on these worthless research agreements have slowly disappeared over the years..Other than our resident researcher JD not one pharma has stepped up with any amount of money to move the needle and validate such claims. Our part-time CEO must be really enjoying her summer vacation. Maybe we just really need one more research paper to really explain things..Endless shares for sale at asking price shouod see .20 before ol Dr.R returns to work end of August

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment